Lalonde James 4
4 · CODEXIS INC · Filed Feb 22, 2019
Insider Transaction Report
Form 4
CODEXIS INCCDXS
Lalonde James
SVP, R&D
Transactions
- Award
Stock Option (Right to Buy)
2019-02-20+100,300→ 100,300 totalExercise: $8.95Exp: 2028-02-20→ Common Stock (100,300 underlying) - Award
Stock Option (Right to Buy)
2019-02-20+23,000→ 23,000 totalExercise: $21.80Exp: 2029-02-20→ Common Stock (23,000 underlying)
Footnotes (2)
- [F1]On February 20, 2018, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2018 with any remaining shares forfeited. On February 20, 2019, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 118% of the target level, which will result in the vesting of the option with respect to 50,150 shares on March 5, 2019 and 50,150 shares on March 5, 2020, in each case subject to the reporting person's continued service to the issuer through such vesting date.
- [F2]Option vests with respect to 25% of the shares subject thereto on February 20, 2020, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 20, 2023.